AAAAAA
Results: 1-25/48
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS, Neuropsychopharmacology, 20(1), 1999, pp. 60-80
Authors:
JOYCE JN
MURRAY AM
HURTIG HI
GOTTLIEB GL
TROJANOWSKI JQ
Citation: Jn. Joyce et al., LOSS OF DOPAMINE D-2 RECEPTORS IN ALZHEIMERS-DISEASE WITH PARKINSONISM BUT NOT PARKINSONS OR ALZHEIMERS-DISEASE, Neuropsychopharmacology, 19(6), 1998, pp. 472-480
Authors:
RYOO HL
PIERROTTI D
JOYCE JN
Citation: Hl. Ryoo et al., DOPAMINE D-3 RECEPTOR IS DECREASED AND D-2 RECEPTOR IS ELEVATED IN THE STRIATUM OF PARKINSONS-DISEASE, Movement disorders, 13(5), 1998, pp. 788-797
Authors:
RIOUX L
NISSANOV J
JOYCE JN
Citation: L. Rioux et al., INCREASED NUMBER OF [I-125] BH-SUBSTANCE-P RECEPTORS IN SCHIZOPHRENIA, Progress in neuro-psychopharmacology & biological psychiatry, 22(8), 1998, pp. 1295-1299
Authors:
THOMAS WS
NEALBELIVEAU BS
JOYCE JN
Citation: Ws. Thomas et al., THERE IS A LIMITED CRITICAL PERIOD FOR DOPAMINES EFFECTS ON D1 RECEPTOR EXPRESSION IN THE DEVELOPING RAT NEOSTRIATUM, Developmental brain research, 111(1), 1998, pp. 99-106
Authors:
NEALBELIVEAU BS
JOYCE JN
Citation: Bs. Nealbeliveau et Jn. Joyce, BEHAVIORAL RESPONSITIVITY TO DOPAMINE-RECEPTOR AGONISTS AFTER EXTENSIVE STRIATAL DOPAMINE LESIONS DURING DEVELOPMENT, Developmental psychobiology, 32(4), 1998, pp. 313-326
Authors:
JOYCE JN
MYERS AJ
GUREVICH E
Citation: Jn. Joyce et al., DOPAMINE D2 RECEPTOR BANDS IN NORMAL HUMAN TEMPORAL CORTEX ARE ABSENTIN ALZHEIMERS-DISEASE, Brain research, 784(1-2), 1998, pp. 7-17
Authors:
GUREVICH EV
KORDOWER J
JOYCE JN
Citation: Ev. Gurevich et al., DOPAMINE D2 RECEPTOR MESSENGER-RNA IS EXPRESSED IN MATURING NEURONS OF THE HUMAN HIPPOCAMPAL AND SUBICULAR FIELDS, NeuroReport, 8(16), 1997, pp. 3605-3610
Authors:
JOYCE JN
GUREVICH EV
Citation: Jn. Joyce et Ev. Gurevich, CORTEX AND SEROTONIN IN SCHIZOPHRENIA - EFFECTS OF ANTIPSYCHOTIC TREATMENT, Schizophrenia research, 24(1-2), 1997, pp. 33-34
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, DOPAMINE D2 RECEPTOR MESSENGER-RNA EXPRESSION IN THE HIPPOCAMPAL-FORMATION OF SCHIZOPHRENICS, Schizophrenia research, 24(1-2), 1997, pp. 86-86
Authors:
JOYCE JN
MEADORWOODRUFF JH
Citation: Jn. Joyce et Jh. Meadorwoodruff, LINKING THE FAMILY OF D-2 RECEPTORS TO NEURONAL CIRCUITS IN HUMAN BRAIN - INSIGHTS INTO SCHIZOPHRENIA, Neuropsychopharmacology, 16(6), 1997, pp. 375-384
Authors:
FROHNA PA
NEALBELIVEAU BS
JOYCE JN
Citation: Pa. Frohna et al., DELAYED PLASTICITY OF THE MESOLIMBIC DOPAMINE SYSTEM FOLLOWING NEONATAL 6-OHDA LESIONS, Synapse, 25(3), 1997, pp. 293-305
Authors:
JOYCE JN
SMUTZER G
WHITTY CJ
MYERS A
BANNON MJ
Citation: Jn. Joyce et al., DIFFERENTIAL MODIFICATION OF DOPAMINE TRANSPORTER AND TYROSINE-HYDROXYLASE MESSENGER-RNAS IN MIDBRAIN OF SUBJECTS WITH PARKINSONS, ALZHEIMERS WITH PARKINSONISM, AND ALZHEIMERS-DISEASE, Movement disorders, 12(6), 1997, pp. 885-897
Authors:
RIOUX L
FROHNA PA
JOYCE JN
SCHNEIDER JS
Citation: L. Rioux et al., THE EFFECTS OF CHRONIC LEVODOPA TREATMENT ON PRESYNAPTIC AND POSTSYNAPTIC MARKERS OF DOPAMINERGIC FUNCTION IN STRIATUM OF PARKINSONIAN MONKEYS, Movement disorders, 12(2), 1997, pp. 148-158
Authors:
JOYCE JN
RYOO HL
Citation: Jn. Joyce et Hl. Ryoo, DOPAMINE D3 RECEPTOR IS DECREASED AND D2 RECEPTOR IS UNCHANGED IN THEFOREBRAIN OF PATIENTS WITH PARKINSONS-DISEASE, Annals of neurology, 42(3), 1997, pp. 71-71
Authors:
JOYCE JN
GOLDSMITH SG
GUREVICH EV
Citation: Jn. Joyce et al., LIMBIC CIRCUITS AND MONOAMINE RECEPTORS - DISSECTING THE EFFECTS OF ANTIPSYCHOTICS FROM DISEASE PROCESSES, Journal of Psychiatric Research, 31(2), 1997, pp. 197-217
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, ALTERATIONS IN THE CORTICAL SEROTONERGIC SYSTEM IN SCHIZOPHRENIA - A POSTMORTEM STUDY, Biological psychiatry, 42(7), 1997, pp. 529-545
Authors:
JOYCE JN
GUREVICH EV
Citation: Jn. Joyce et Ev. Gurevich, ANATOMY OF D2 AND D3 RECEPTOR NEURONS IN THE HUMAN MEDIAL TEMPORAL-LOBE, Biological psychiatry, 41, 1997, pp. 182-182
Authors:
GOLDSMITH SK
SHAPIRO RM
JOYCE JN
Citation: Sk. Goldsmith et al., DISRUPTED PATTERN OF D-2 DOPAMINE-RECEPTORS IN THE TEMPORAL-LOBE IN SCHIZOPHRENIA - A POSTMORTEM STUDY, Archives of general psychiatry, 54(7), 1997, pp. 649-658
Authors:
GUREVICH EV
BORDELON Y
SHAPIRO RM
ARNOLD SE
GUR RE
JOYCE JN
Citation: Ev. Gurevich et al., MESOLIMBIC DOPAMINE D-3 RECEPTORS AND USE OF ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA - A POSTMORTEM STUDY, Archives of general psychiatry, 54(3), 1997, pp. 225-232
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, COMPARISON OF [H-3] PAROXETINE AND [H-3] CYANOIMIPRAMINE FOR QUANTITATIVE MEASUREMENT OF SEROTONIN TRANSPORTER SITES IN HUMAN BRAIN, Neuropsychopharmacology, 14(5), 1996, pp. 309-323
Authors:
GOLDSMITH SK
JOYCE JN
Citation: Sk. Goldsmith et Jn. Joyce, DOPAMINE D2 RECEPTORS ARE ORGANIZED IN BANDS IN NORMAL HUMAN TEMPORALCORTEX, Neuroscience, 74(2), 1996, pp. 435-451
Authors:
JOYCE JN
FROHNA PA
NEALBELIVEAU BS
Citation: Jn. Joyce et al., FUNCTIONAL AND MOLECULAR DIFFERENTIATION OF THE DOPAMINE SYSTEM INDUCED BY NEONATAL DENERVATION, Neuroscience and biobehavioral reviews, 20(3), 1996, pp. 453-486
Authors:
SOLBRIG MV
KOOB GF
JOYCE JN
LIPKIN WI
Citation: Mv. Solbrig et al., A NEURAL SUBSTRATE OF HYPERACTIVITY IN BORNA-DISEASE - CHANGES IN BRAIN DOPAMINE-RECEPTORS, Virology, 222(2), 1996, pp. 332-338
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, [I-125] RTI-55 BINDING TO THE SEROTONIN TRANSPORTER, [I-125] LSD BINDING TO 5-HT2 AND [H-3] 8-OH-DIPAT BINDING TO 5-HT1A RECEPTORS IN SCHIZOPHRENIC PREFRONTAL CORTEX, Schizophrenia research, 15(1-2), 1995, pp. 59-59